Detection of Colonic Neoplasia in Vivo Using Near-Infrared-labeled Peptide Targeting Cmet.

Xiaoli Wu,Juan Zhou,Fa Wang,Xiaoqing Meng,Jing Chen,Tse-Shao Chang,Miki Lee,Gaoming Li,Xue Li,Henry D. Appelman,Rork Kuick,Thomas D. Wang

DOI: https://doi.org/10.1038/s41598-019-54385-7

IF: 4.6

2019-01-01

Scientific Reports

Abstract:White light colonoscopy is widely used to detect colorectal polyps, but flat and depressed lesions are often missed. Here, we report a molecular imaging strategy to potentially improve diagnostic performance by developing a fluorescently-labeled peptide specific for cMet. This 7mer is conjugated to Cy5.5, a near-infrared (NIR) cyanine dye. Specific binding to cMet was confirmed by cell staining, knockdown, and competition assays. The probe showed high binding affinity (k(d) = 57 nM) and fast onset (k = 1.6 min) to support topical administration in vivo. A mouse model (CPC;Apc) that develops spontaneous adenomas that overexpress cMet was used to demonstrate feasibility for real time in vivo imaging. This targeting ligand showed significantly higher target-to-background (T/B) ratio for polypoid and non-polypoid lesions by comparison with a scrambled control peptide. Immunofluorescence staining on human colon specimens show significantly greater binding to tubular and sessile serrated adenomas versus hyperplastic polyps and normal mucosa. These results demonstrate a peptide specific for cMet that is promising for endoscopic detection of pre-malignant lesions and guiding of tissue biopsy.